Zuckerberg-backed Biohub bets $500M on AI biology (3 minute read)
Mark Zuckerberg and Priscilla Chan's nonprofit is investing $500 million to build AI models that simulate the human body, betting that scaling compute and biological data will help cure diseases.
What: Biohub, the nonprofit backed by Zuckerberg and Chan, is committing $500 million to develop AI-powered simulations of human biology, splitting the funding between internal research ($400 million) and external grants ($100 million).
Why it matters: The initiative tests whether AI scaling laws apply to biology—whether throwing more compute and data at biological systems will yield breakthrough disease models and treatments, potentially transforming drug discovery and medical research.
Original article
Mark Zuckerberg and Priscilla Chan's nonprofit, Biohub, is committing $500 million to help create better AI simulations of the human body. Biohub's long-term goal is to cure all human diseases through the intersection of AI and biology. It is betting that more data and compute will produce more useful models. Of the $500 million, Biohub will spend $400 million on its own work and $100 million to spur others.